会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明申请
    • STRAINER FOR A BILGE PUMP
    • 超级泵的过滤器
    • WO2010112214A1
    • 2010-10-07
    • PCT/EP2010/002067
    • 2010-03-31
    • MUNSTER SIMMS ENGINEERING LIMITEDBOVILL, Richard
    • BOVILL, Richard
    • F04B49/02
    • F04B49/02F04B53/20F04D15/0218F04D29/708
    • A straining device for a drainage pump, the straining device comprising a body defining an inner chamber; at least one straining element by which liquid may enter the chamber; and at least one outlet by which liquid may leave the chamber. The straining device further includes a liquid level sensor arranged to detect the level of a liquid in which said straining device is located during use and, upon determining that said liquid level exceeds a threshold, to cause an activation signal to be sent to said pump. The liquid level sensor comprises non-contact sensing means such as an electric field sensor. The sensor is located at the top of the straining device and arranged to project its sensing field upwardly.
    • 一种用于排水泵的应变装置,所述应变装置包括限定内腔的主体; 至少一个应变元件,液体可以通过该元件进入腔室; 以及至少一个出口,液体可以通过该出口离开室。 应变装置还包括液位传感器,布置成在使用期间检测所述应变装置所在的液体的水平,并且在确定所述液位超过阈值时,使得激活信号被发送到所述泵。 液位传感器包括诸如电场传感器的非接触检测装置。 传感器位于应变装置的顶部,并布置成向上突出其感测场。
    • 5. 发明申请
    • THERAPEUTICALLY USEFUL ANTIBACTERIAL COMPOUNDS
    • 可治疗有用的抗生素化合物
    • WO2005067939A1
    • 2005-07-28
    • PCT/GB2005/000131
    • 2005-01-17
    • OXOID LIMITEDBOVILL, RichardDRUGGAN, Patrick
    • BOVILL, RichardDRUGGAN, Patrick
    • A61K31/662
    • A61K31/662A61K47/54A61K47/6903A61K47/6943
    • Disclosed is a compound which has antibiotic activity in vivo in a mammalian, preferably a human, subject, the compound comprising an uptake moiety linked to a bactericidal or bacteriostatic toxic moiety, said uptake moiety facilitating uptake of the compound by bacteria on which the toxic moiety exerts a bactericidal or bacteriostatic effect, wherein: (a) the compound is non-toxic for mammalian subjects; (b) the linkage between the uptake moiety and the toxic moiety is one which is cleavable by an enzyme or enzymes produced by the bacteria to be killed/inhibited, but is not readily cleavable by enzymes produced by the subject and to which the compound is exposed prior to contacting the bacteria; and (c) the toxic moiety, when cleaved from the uptake moiety, is toxic for the bacteria, but not toxic for the subject.
    • 公开了一种在哺乳动物,优选人类受试者体内具有抗生素活性的化合物,该化合物包含与杀菌或抑菌毒性部分连接的摄取部分,所述吸收部分便于由细菌摄取化合物,其中毒性部分 发挥杀菌或抑菌作用,其中:(a)该化合物对哺乳动物受试者无毒; (b)摄取部分和毒性部分之间的连接是可被酶杀死的酶或由被杀死/抑制的细菌产生的酶,但不容易被受试者产生的酶切割,并且化合物 在接触细菌之前暴露; 和(c)当从摄取部分切割时,毒性部分对细菌是有毒的,但对受试者无毒性。